Searchable abstracts of presentations at key conferences in endocrinology

ea0073oc10.4 | Oral Communications 10: Thyroid | ECE2021

Targeting TSHR and ICAM-1 for treatment of Graves’ disease in BALB/c mice

Zheng Wei , Wang Xuan , Li Wang , Wang Shen , Tan Jian , Jia Qiang , Meng Zhaowei , Rui Zhongying

ObjectiveIn BALB/c mice with GD model, the TSHR and ICAM-1 were targeted for treatment, and new approaches to GD targeted therapy were explored.MethodsThe siRNA targeting TSHR and the ICAM-1 mAb specifically binding ICAM-1 were designed and synthesized. Thirty GD model mice were randomly divided into siRNA treatment group, ICAM-1 mAb treatment group, and untreated GD group, with 10 mice in each group, and 10 ...

ea0070aep942 | Thyroid | ECE2020

Predictive value of free triiodothyronine within normal range on cardiovascular events in a Chinese cohort with coronary artery disease: Direct effect and mediation effect by TG

Wen Jun , Su Fei , Li Xuan , Wu Na-Qiong , Gao Ying , Liu Geng , Dong Qian , Tang Yi-Da , Li Jian-Jun , Guo Yuan-Lin

Background and aims: Coronary artery disease (CAD) plays an important role in global mortality worldwide. Risk assessment for patients with CAD through free triiodothyronine (FT3) remains unclear. Therefore, we aimed to investigate the impact of FT3 on the prognosis of patients with CAD.Methods: A total of 0 patients with CAD and available FT3 data, and without overt thyroid disease were enrolled in this study and grouped by tertiles. The primary outcome...